Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma

Table 2

Patient recruitment summary.

Planned	Screened/consented	Screen failure	Off study	Vaccinated	Completed study
30	27	5	14	15	8